107 related articles for article (PubMed ID: 38798269)
1. Cuproptosis associated cytoskeletal destruction contributes to podocyte injury in chronic kidney disease.
Li H; Fu Y; Xu Y; Miao H; Wang H; Zhang T; Mei X; He Y; Zhang A; Ge X
Am J Physiol Cell Physiol; 2024 May; ():. PubMed ID: 38798269
[TBL] [Abstract][Full Text] [Related]
2. Protective role of cyclosporine A and minocycline on mitochondrial disequilibrium-related podocyte injury and proteinuria occurrence induced by adriamycin.
Guan N; Ren YL; Liu XY; Zhang Y; Pei P; Zhu SN; Fan Q
Nephrol Dial Transplant; 2015 Jun; 30(6):957-69. PubMed ID: 25646018
[TBL] [Abstract][Full Text] [Related]
3. tRF-003634 alleviates adriamycin-induced podocyte injury by reducing the stability of TLR4 mRNA.
Gao X; Qiao Y; Li S; Shi H; Qu G; Ji J; Gan W; Zhang A
PLoS One; 2023; 18(10):e0293043. PubMed ID: 37856510
[TBL] [Abstract][Full Text] [Related]
4. Hyperoside alleviates adriamycin-induced podocyte injury via inhibiting mitochondrial fission.
Chen Z; An X; Liu X; Qi J; Ding D; Zhao M; Duan S; Huang Z; Zhang C; Wu L; Zhang B; Zhang A; Yuan Y; Xing C
Oncotarget; 2017 Oct; 8(51):88792-88803. PubMed ID: 29179476
[TBL] [Abstract][Full Text] [Related]
5. Dysfunction of the PGC-1α-mitochondria axis confers adriamycin-induced podocyte injury.
Zhu C; Xuan X; Che R; Ding G; Zhao M; Bai M; Jia Z; Huang S; Zhang A
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1410-7. PubMed ID: 24808537
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of astragalosides from Radix Astragali on adriamycin-induced podocyte injury.
Sai YP; Song YC; Chen XX; Luo X; Liu J; Cui WJ
Exp Ther Med; 2018 May; 15(5):4485-4490. PubMed ID: 29731833
[TBL] [Abstract][Full Text] [Related]
7. ATF3/SPI1/SLC31A1 Signaling Promotes Cuproptosis Induced by Advanced Glycosylation End Products in Diabetic Myocardial Injury.
Huo S; Wang Q; Shi W; Peng L; Jiang Y; Zhu M; Guo J; Peng D; Wang M; Men L; Huang B; Lv J; Lin L
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675183
[TBL] [Abstract][Full Text] [Related]
8. Cope with copper: From molecular mechanisms of cuproptosis to copper-related kidney diseases.
Zou Y; Wu S; Xu X; Tan X; Yang S; Chen T; Zhang J; Li S; Li W; Wang F
Int Immunopharmacol; 2024 May; 133():112075. PubMed ID: 38663316
[TBL] [Abstract][Full Text] [Related]
9. Plectin protects podocytes from adriamycin-induced apoptosis and F-actin cytoskeletal disruption through the integrin α6β4/FAK/p38 MAPK pathway.
Ni Y; Wang X; Yin X; Li Y; Liu X; Wang H; Liu X; Zhang J; Gao H; Shi B; Zhao S
J Cell Mol Med; 2018 Nov; 22(11):5450-5467. PubMed ID: 30187999
[TBL] [Abstract][Full Text] [Related]
10. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
[TBL] [Abstract][Full Text] [Related]
11. Engineering antioxidant ceria-zirconia nanomedicines for alleviating podocyte injury in rats with adriamycin-induced nephrotic syndrome.
Liu L; Chang M; Yang R; Ding L; Chen Y; Kang Y
J Nanobiotechnology; 2023 Oct; 21(1):384. PubMed ID: 37858242
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
[TBL] [Abstract][Full Text] [Related]
13. ManNAc protects against podocyte pyroptosis via inhibiting mitochondrial damage and ROS/NLRP3 signaling pathway in diabetic kidney injury model.
Gao Y; Ma Y; Xie D; Jiang H
Int Immunopharmacol; 2022 Jun; 107():108711. PubMed ID: 35338958
[TBL] [Abstract][Full Text] [Related]
14. Cuproptosis mediates copper-induced testicular spermatogenic cell death.
Zhang JY; Yu XJ; Li JJ; Xiao Y; Li GS; Yang F; Dong L
Asian J Androl; 2024 Jan; 26(3):295-301. PubMed ID: 38284772
[TBL] [Abstract][Full Text] [Related]
15. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease.
Wang D; Tian Z; Zhang P; Zhen L; Meng Q; Sun B; Xu X; Jia T; Li S
Biomed Pharmacother; 2023 Jul; 163():114830. PubMed ID: 37150036
[TBL] [Abstract][Full Text] [Related]
16. The RNA binding protein hnRNPK protects against adriamycin-induced podocyte injury.
Zhao S; Feng J; Li J; Cao R; Zhang Y; Yang S; Yin L
Ann Transl Med; 2021 Aug; 9(16):1303. PubMed ID: 34532440
[TBL] [Abstract][Full Text] [Related]
17. BaoShenTongLuo formula protects against podocyte injury by regulating AMPK-mediated mitochondrial biogenesis in diabetic kidney disease.
Guo Y; Wang M; Liu Y; Pang Y; Tian L; Zhao J; Liu M; Shen C; Meng Y; Wang Y; Cai Z; Zhao W
Chin Med; 2023 Mar; 18(1):32. PubMed ID: 36967383
[TBL] [Abstract][Full Text] [Related]
18. Changes in cuproptosis-related gene expression in periodontitis: An integrated bioinformatic analysis.
Liu N; He Y; Chen X; Qiu G; Wu Y; Shen Y
Life Sci; 2024 Feb; 338():122388. PubMed ID: 38181851
[TBL] [Abstract][Full Text] [Related]
19. The copper transporter, SLC31A1, transcriptionally activated by ELF3, imbalances copper homeostasis to exacerbate cisplatin-induced acute kidney injury through mitochondrial dysfunction.
Qiu Z; Liu Q; Wang L; Xiong Y; Wu J; Wang M; Yan X; Deng H
Chem Biol Interact; 2024 Apr; 393():110943. PubMed ID: 38462020
[TBL] [Abstract][Full Text] [Related]
20. The effect of lipid metabolism on cuproptosis-inducing cancer therapy.
Zhong Y; Zeng W; Chen Y; Zhu X
Biomed Pharmacother; 2024 Mar; 172():116247. PubMed ID: 38330710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
